glp-1 gastrointestinal obstruction lawyer in michigan Ozempic® Lawsuit Michigan obesity trends GLP-1

GLP-1 medications, known for helping with weight loss, offer surprising benefits for people with kidney disease

elara | 416 followers on LinkedIn

Altimmune just made a big move in the world of GLP-1 research, but this time, its not about obesity.The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD

Stopping or interrupting GLP-1 receptor agonists “erode and could ultimately reverse&rdquo

Drug interactions : Avoid co-administration with drugs such as DPP-4 inhibitors

This update elevates obesity within the global noncommunicable disease agenda and sets a clear mandate for action